article · Kidney International Reports
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK-9), the new biomarker interfering in lipid homeostasis, has not been explored among sub-Saharan African receiving maintenance hemodialysis. The aim of this study was to investigate the association between PCSK-9, dyslipidemia and risk of cardiovascular events in a population of black Africans.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ekir.2021.03.608
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
